Sympathomimetic Drug Toxicity

Sympathomimetic drug toxicity is a critical medical emergency where the body's adrenergic systems are pushed into dangerous overdrive. Whether from illicit drugs like cocaine and methamphetamine or therapeutic misadventures, the resulting surge of catecholamines can lead to life-threatening hypertension, cardiac injury, and metabolic collapse. Understanding this toxidrome is essential because the instinctive treatments for a typical heart attack or high blood pressure can be fatal here, demanding a specific and nuanced clinical approach.

Pathophysiology: The Storm of Catecholamines

At its core, sympathomimetic toxicity is a state of extreme catecholamine excess. Catecholamines, such as epinephrine and norepinephrine, are the body's primary "fight or flight" neurotransmitters. Sympathomimetic drugs mimic or potentiate their effects by various mechanisms, leading to a massive, unopposed stimulation of alpha and beta-adrenergic receptors throughout the body. This systemic overstimulation produces a predictable constellation of signs and symptoms: severe hypertension (high blood pressure), tachycardia (rapid heart rate), hyperthermia (elevated body temperature), mydriasis (dilated pupils), and profound agitation or psychosis. The hyperthermia is particularly dangerous, as it can be malignant, leading to muscle breakdown (rhabdomyolysis), kidney failure, and disseminated intravascular coagulation.

Cocaine: The Vasospastic Threat

Cocaine exemplifies the unique dangers of this drug class. It blocks the reuptake of norepinephrine, dopamine, and serotonin at nerve terminals, causing a buildup of these neurotransmitters. Its cardiac toxicity is twofold. First, the catecholamine surge increases heart rate and blood pressure, dramatically raising the heart's oxygen demand. Second, and more specifically, cocaine induces coronary vasospasm—a sudden, intense narrowing of the heart's arteries. This combination of increased demand and reduced supply can directly cause a myocardial infarction (heart attack), even in young individuals with otherwise healthy coronary arteries. The agitation and hyperthermia further strain the cardiovascular system, creating a vicious cycle of escalating toxicity.

Amphetamines and Related Stimulants

Amphetamines (e.g., methamphetamine, MDMA) and prescription stimulants operate through a similar yet distinct mechanism: they cause the massive release of catecholamines from neuronal storage vesicles, in addition to blocking reuptake. The clinical picture is broadly similar to cocaine toxicity, featuring hypertension, tachycardia, hyperthermia, mydriasis, and agitation. However, amphetamines often have longer durations of action and can involve more pronounced serotonin pathways, blurring the line with serotonin syndrome. Chronic use can lead to cardiomyopathy and severe psychiatric manifestations. The hyperthermia from amphetamines like MDMA is especially notorious, often occurring in the context of raves and physical exertion, leading to fatal cascades.

Clinical Management: Sedation and Specific Antagonists

The management of sympathomimetic toxicity is a stepwise process that prioritizes calming the storm. Benzodiazepines (e.g., lorazepam, diazepam) are the unequivocal first-line treatment. They work by reducing central nervous system-driven agitation, which in turn lowers heart rate, blood pressure, body temperature, and the risk of seizures. Adequate benzodiazepine dosing is crucial—"sedation to calm" is the goal, often requiring higher than typical doses.

For refractory hypertension that does not respond to sedation, the specific antidote is phentolamine. This drug is a direct, non-selective alpha-adrenergic receptor antagonist. It directly counteracts the potent vasoconstriction caused by alpha-receptor stimulation, rapidly lowering blood pressure. Nitroprusside or nitroglycerin are alternative vasodilators. Importantly, pure beta-blockers (like metoprolol or propranolol) are contraindicated in acute cocaine toxicity. Blocking beta receptors leaves alpha stimulation unopposed, leading to paradoxic worsening of vasoconstriction and hypertension—a potentially lethal effect.

Common Pitfalls

1. Reaching for a Beta-Blocker First: The most critical error is administering a beta-blocker to a patient with suspected cocaine-induced chest pain or hypertension. As outlined, this can precipitate a worsening coronary vasospasm and hypertensive crisis. The correct sequence is always benzodiazepines first, then specific vasodilators like phentolamine if needed.
2. Misdiagnosing Serotonin Syndrome: There is significant overlap between serotonin syndrome and the sympathomimetic toxidrome, as both can cause agitation, tachycardia, hyperthermia, and clonus. The distinction is vital because specific treatments differ. Key features pointing toward serotonin syndrome include a history of serotonergic drug combinations, the presence of specific neuromuscular findings like clonus and hyperreflexia (particularly horizontal clonus), and the absence of mydriasis (pupils may be normal or dilated). Cyproheptadine is a treatment for serotonin syndrome but not for pure sympathomimetic toxicity.
3. Under-treating Hyperthermia: Treating hyperthermia with mere antipyretics (like acetaminophen) is ineffective. This is a hypermetabolic state generated by muscle activity and impaired heat dissipation. Rapid, active cooling (ice baths, misting fans) and chemical sedation with benzodiazepines are required to prevent fatal rhabdomyolysis and organ failure.
4. Anchoring on Myocardial Infarction Protocol Alone: While a patient may have ECG changes and elevated troponin, rushing to standard MI therapies can be harmful. Fibrinolytics (clot-busters) are risky in the context of uncontrolled hypertension and may not address the primary vasospastic cause. The initial focus must remain on benzodiazepines and anti-adrenergic measures, with aspirin and heparin considered only once the adrenergic crisis is controlled.

Summary

• Sympathomimetic toxicity from drugs like cocaine and amphetamines results in a life-threatening catecholamine excess, manifesting as hypertension, tachycardia, hyperthermia, mydriasis, and agitation.
• Cocaine uniquely risks causing myocardial infarction through coronary vasospasm combined with increased myocardial oxygen demand.
• Benzodiazepines are the cornerstone of first-line treatment, addressing agitation and its downstream cardiovascular and hyperthermic consequences.
• Pure beta-blockers are contraindicated in acute cocaine toxicity due to the risk of unopposed alpha-agony, worsening vasoconstriction and hypertension.
• For severe, sedation-resistant hypertension, the specific vasodilator phentolamine (an alpha-antagonist) is the agent of choice.
• Clinicians must carefully distinguish sympathomimetic toxidrome from serotonin syndrome, as their management pathways diverge, though significant symptom overlap exists.